Variant report

Variant	nsv1018516
Chromosome Location	chr5:101013963-101270305
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:101014356-101014620	HepG2	liver:	n/a	n/a
2	ATF1	chr5:101236378-101236518	K562	blood:	n/a	n/a
3	BACH1	chr5:101015688-101015888	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr5:101014228-101014574	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr5:101098504-101098821	H1-hESC	embryonic stem cell:	n/a	n/a
6	BCL3	chr5:101025874-101026214	GM12878	blood:	n/a	n/a
7	BCL3	chr5:101028089-101028291	GM12878	blood:	n/a	n/a
8	BHLHE40	chr5:101014326-101014676	GM12878	blood:	n/a	n/a
9	BRCA1	chr5:101064760-101064960	H1-hESC	embryonic stem cell:	n/a	n/a
10	CBX3	chr5:101014327-101014549	K562	blood:	n/a	n/a
11	CEBPB	chr5:101053782-101054140	Hela-S3	cervix:	n/a	chr5:101053958-101053969
12	CEBPB	chr5:101015614-101015791	A549	lung:	n/a	chr5:101015688-101015701
13	CEBPB	chr5:101015526-101015987	A549	lung:	n/a	chr5:101015688-101015701
14	CEBPB	chr5:101127405-101127502	HepG2	liver:	n/a	chr5:101127458-101127469
15	CEBPB	chr5:101085665-101085814	K562	blood:	n/a	chr5:101085696-101085709
16	CEBPB	chr5:101230716-101231013	ECC-1	luminal epithelium:	n/a	chr5:101230870-101230879 chr5:101230868-101230881 chr5:101230868-101230881 chr5:101230870-101230879 chr5:101230870-101230879 chr5:101230869-101230880
17	CEBPB	chr5:101165030-101165279	A549	lung:	n/a	n/a
18	CEBPB	chr5:101165091-101165242	K562	blood:	n/a	n/a
19	CEBPB	chr5:101240459-101240842	HepG2	liver:	n/a	chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240645-101240654 chr5:101240645-101240654 chr5:101240644-101240655 chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240643-101240656 chr5:101240643-101240654
20	CEBPB	chr5:101040311-101040408	A549	lung:	n/a	n/a
21	CEBPB	chr5:101240494-101240820	A549	lung:	n/a	chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240645-101240654 chr5:101240645-101240654 chr5:101240644-101240655 chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240643-101240656 chr5:101240643-101240654
22	CEBPB	chr5:101230716-101231019	K562	blood:	n/a	chr5:101230870-101230879 chr5:101230868-101230881 chr5:101230868-101230881 chr5:101230870-101230879 chr5:101230870-101230879 chr5:101230869-101230880
23	CEBPB	chr5:101053829-101054108	HepG2	liver:	n/a	chr5:101053958-101053969
24	CEBPB	chr5:101081760-101081990	H1-hESC	embryonic stem cell:	n/a	n/a
25	CEBPB	chr5:101240532-101240819	Hela-S3	cervix:	n/a	chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240645-101240654 chr5:101240645-101240654 chr5:101240644-101240655 chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240643-101240656 chr5:101240643-101240654
26	CEBPB	chr5:101142779-101143049	HepG2	liver:	n/a	chr5:101142918-101142929
27	CEBPB	chr5:101085573-101085868	A549	lung:	n/a	chr5:101085696-101085709
28	CEBPB	chr5:101250910-101251177	A549	lung:	n/a	chr5:101251033-101251044
29	CEBPB	chr5:101230712-101231045	H1-hESC	embryonic stem cell:	n/a	chr5:101230870-101230879 chr5:101230868-101230881 chr5:101230868-101230881 chr5:101231019-101231031 chr5:101230870-101230879 chr5:101230870-101230879 chr5:101230869-101230880
30	CEBPB	chr5:101230709-101231058	HepG2	liver:	n/a	chr5:101230870-101230879 chr5:101230868-101230881 chr5:101230868-101230881 chr5:101231019-101231031 chr5:101230870-101230879 chr5:101230870-101230879 chr5:101230869-101230880
31	CEBPB	chr5:101117728-101117741	K562	blood:	n/a	n/a
32	CEBPB	chr5:101240435-101240815	MCF-7	breast:	n/a	chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240645-101240654 chr5:101240645-101240654 chr5:101240644-101240655 chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240643-101240656 chr5:101240643-101240654
33	CEBPB	chr5:101240546-101240711	K562	blood:	n/a	chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240645-101240654 chr5:101240645-101240654 chr5:101240644-101240655 chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240643-101240656 chr5:101240643-101240654
34	CEBPB	chr5:101230700-101231060	IMR90	lung:	n/a	chr5:101230870-101230879 chr5:101230868-101230881 chr5:101230868-101230881 chr5:101231019-101231031 chr5:101230870-101230879 chr5:101230870-101230879 chr5:101230869-101230880
35	CEBPB	chr5:101035956-101036089	A549	lung:	n/a	n/a
36	CEBPB	chr5:101015548-101015857	A549	lung:	n/a	chr5:101015688-101015701
37	CEBPB	chr5:101142819-101143071	A549	lung:	n/a	chr5:101142918-101142929
38	CEBPB	chr5:101240500-101240839	IMR90	lung:	n/a	chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240645-101240654 chr5:101240645-101240654 chr5:101240644-101240655 chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240643-101240656 chr5:101240643-101240654
39	CEBPB	chr5:101117582-101117899	HepG2	liver:	n/a	chr5:101117734-101117745 chr5:101117735-101117744
40	CEBPB	chr5:101240483-101240827	ECC-1	luminal epithelium:	n/a	chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240645-101240654 chr5:101240645-101240654 chr5:101240644-101240655 chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240643-101240656 chr5:101240643-101240654
41	CEBPB	chr5:101036520-101036845	HepG2	liver:	n/a	chr5:101036723-101036736
42	CEBPB	chr5:101042483-101042715	HepG2	liver:	n/a	n/a
43	CEBPB	chr5:101250923-101251163	HepG2	liver:	n/a	chr5:101251033-101251044
44	CEBPB	chr5:101240441-101240860	ECC-1	luminal epithelium:	n/a	chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240645-101240654 chr5:101240645-101240654 chr5:101240644-101240655 chr5:101240645-101240654 chr5:101240643-101240656 chr5:101240643-101240656 chr5:101240643-101240654
45	CHD1	chr5:101014314-101014648	GM12878	blood:	n/a	n/a
46	CTCF	chr5:101119280-101119430	BE2_C	brain:	n/a	n/a
47	CTCF	chr5:101014440-101014590	Caco-2	colon:	n/a	chr5:101014484-101014505 chr5:101014489-101014507
48	CTCF	chr5:101014420-101014570	GM12868	blood:	n/a	chr5:101014484-101014505 chr5:101014489-101014507
49	CTCF	chr5:101064720-101064932	MCF-7	breast:	n/a	n/a
50	CTCF	chr5:101064640-101064790	GM12868	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:101119128-101119178	HL-60	blood:	n/a
2	chr5:101119128-101119178	HL-60	blood:	n/a
3	chr5:101119420-101119470	HMEC	breast:	n/a
4	chr5:101119128-101119178	HCF	heart:	n/a
5	chr5:101119128-101119178	AoSMC	blood vessel:	n/a
6	chr5:101119420-101119470	AG04450	lung:	fetal
7	chr5:101119128-101119178	GM12892	blood:	n/a
8	chr5:101119420-101119470	RPTEC	kidney:	n/a
9	chr5:101119766-101119816	MCF-7	breast:	n/a
10	chr5:101119420-101119470	HepG2	liver:	n/a
11	chr5:101119566-101119616	PFSK-1	brain:	n/a
12	chr5:101119420-101119470	Jurkat	blood:	n/a
13	chr5:101119084-101119134	Hela-S3	cervix:	n/a
14	chr5:101119766-101119816	MCF10A-Er-Src	breast:	n/a
15	chr5:101119420-101119470	MCF-7	breast:	n/a
16	chr5:101119420-101119470	GM12891	blood:	n/a
17	chr5:101119084-101119134	ProgFib	skin:	n/a
18	chr5:101119128-101119178	HUVEC	blood vessel:	n/a
19	chr5:101119566-101119616	HCF	heart:	n/a
20	chr5:101119128-101119178	SK-N-SH	brain:	n/a
21	chr5:101119566-101119616	A549	lung:	n/a
22	chr5:101119128-101119178	Jurkat	blood:	n/a
23	chr5:101119766-101119816	NHDF-neo	bronchial:	n/a
24	chr5:101119420-101119470	LNCaP	prostate:	n/a
25	chr5:101119420-101119470	T-47D	breast:	n/a
26	chr5:101119420-101119470	HRE	kidney:	n/a
27	chr5:101119420-101119470	NHDF-neo	bronchial:	n/a
28	chr5:101119766-101119816	ECC-1	luminal epithelium:	n/a
29	chr5:101119420-101119470	IMR90	lung:	fetal
30	chr5:101119420-101119470	GM12878	blood:	n/a
31	chr5:101119420-101119470	NT2-D1	testis:	n/a
32	chr5:101119766-101119816	PANC-1	pancreas:	n/a
33	chr5:101119084-101119134	AG09309	skin:	n/a
34	chr5:101119766-101119816	NT2-D1	testis:	n/a
35	chr5:101119566-101119616	HAEpiC	amniotic membrane:	n/a
36	chr5:101119566-101119616	AG04450	lung:	fetal
37	chr5:101119566-101119616	Hela-S3	cervix:	n/a
38	chr5:101119084-101119134	GM12891	blood:	n/a
39	chr5:101119766-101119816	Caco-2	colon:	n/a
40	chr5:101119084-101119134	CMK	blood:	n/a
41	chr5:101119766-101119816	IMR90	lung:	fetal
42	chr5:101119420-101119470	SKMC	muscle:	n/a
43	chr5:101119420-101119470	HIPEpiC	eye:	n/a
44	chr5:101119566-101119616	HRPEpiC	eye:	n/a
45	chr5:101119128-101119178	HPAEpiC	pulmonary alveolar:	n/a
46	chr5:101119420-101119470	CMK	blood:	n/a
47	chr5:101119566-101119616	Hepatocyte	liver:	n/a
48	chr5:101119420-101119470	Caco-2	colon:	n/a
49	chr5:101119128-101119178	GM12891	blood:	n/a
50	chr5:101119420-101119470	Hepatocyte	liver:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:101006866..101009211-chr5:101203107..101204677,2	MCF-7	breast:
2	chr5:101053272..101055786-chr5:101055879..101057749,3	MCF-7	breast:
3	chr5:100926018..100926756-chr5:101014023..101014890,2	MCF-7	breast:
4	chr5:101216484..101218050-chr5:101219554..101221470,2	MCF-7	breast:
5	chr10:68291165..68291817-chr5:101132057..101132805,2	MCF-7	breast:
6	chr5:100977422..100978164-chr5:101014049..101014730,4	MCF-7	breast:
7	chr5:100801149..100803807-chr5:101019076..101021697,2	K562	blood:
8	chr5:101078843..101080982-chr5:101098462..101100344,2	MCF-7	breast:
9	chr5:101013149..101015259-chr5:101019729..101021246,2	MCF-7	breast:
10	chr5:101216484..101218050-chr5:101219554..101221470,2	MCF-7	breast:
11	chr5:101137073..101139756-chr5:101141662..101143533,2	MCF-7	breast:
12	chr5:100950934..100952627-chr5:101023886..101026706,2	K562	blood:
13	chr5:100726516..100727169-chr5:101014073..101014596,2	MCF-7	breast:
14	chr5:101137073..101139756-chr5:101141662..101143533,2	MCF-7	breast:
15	chr5:101209236..101211408-chr5:101214038..101216724,2	K562	blood:
16	chr5:101053272..101055786-chr5:101055879..101057749,3	MCF-7	breast:
17	chr5:101078843..101080982-chr5:101098462..101100344,2	MCF-7	breast:
18	chr5:101209236..101211408-chr5:101214038..101216724,2	K562	blood:
19	chr5:101013149..101015259-chr5:101019729..101021246,2	MCF-7	breast:

Variant related genes	Relation type
OR7H2P	TF binding region
OR7H2P	CpG island

Extended variants
information (count: 2301 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:2301 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs534299422	chr5:101013998-101013999	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs552113878	chr5:101014014-101014015	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs570643720	chr5:101014070-101014071	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs11948398	chr5:101014081-101014082	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs188401462	chr5:101014102-101014103	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs77306435	chr5:101014104-101014105	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs181886252	chr5:101014109-101014110	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs574487307	chr5:101014188-101014189	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs535066872	chr5:101014201-101014202	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs148036242	chr5:101014213-101014214	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
11	rs576726510	chr5:101014240-101014241	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs75036074	chr5:101014269-101014270	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
13	rs545650027	chr5:101014277-101014278	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
14	rs17138643	chr5:101014287-101014288	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
15	rs576996486	chr5:101014299-101014300	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs544508078	chr5:101014352-101014353	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs562804550	chr5:101014366-101014367	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs78330589	chr5:101014381-101014382	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs556997927	chr5:101014394-101014395	Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
20	rs566567744	chr5:101014453-101014454	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs114929601	chr5:101014461-101014462	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs186332198	chr5:101014463-101014464	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs191133477	chr5:101014475-101014476	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs527814484	chr5:101014502-101014503	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs552604484	chr5:101014517-101014518	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs75824594	chr5:101014521-101014522	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs531483985	chr5:101014551-101014552	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs370170969	chr5:101014609-101014610	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs75562843	chr5:101014656-101014657	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs547929498	chr5:101014755-101014756	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs78754438	chr5:101014756-101014757	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs376094953	chr5:101014762-101014763	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs575383059	chr5:101014803-101014804	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs7720796	chr5:101014813-101014814	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs577920234	chr5:101014842-101014843	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs539182929	chr5:101014859-101014860	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs557504589	chr5:101014886-101014887	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs77385388	chr5:101014889-101014890	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs577035779	chr5:101014925-101014926	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs114507742	chr5:101015010-101015011	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs77492555	chr5:101015022-101015023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs556338181	chr5:101015061-101015062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs575061299	chr5:101015074-101015075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs542492143	chr5:101015075-101015076	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs560299270	chr5:101015088-101015089	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs533509926	chr5:101015089-101015090	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs68002326	chr5:101015093-101015094	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs367988166	chr5:101015108-101015109	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs114863063	chr5:101015128-101015129	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs183241438	chr5:101015139-101015140	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD
Renal cell carcinoma	18194544	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Cancer	20164920	CNVD
Myelodysplastic syndrome	21251322	CNVD
abnormal development	18461090	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16774939	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Multiple myeloma	17550852	CNVD
Glioblastoma multiforme	22286061	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Ovarian cancer	21720365	CNVD
Prostate cancer	16461572	CNVD
Neurocytoma	17123091	CNVD
Salivary gland tumor	18059337	CNVD
Bipolar disorder	19114987	CNVD
Breast cancer	21509527	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:340 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:101012800-101014200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
2	chr5:101013600-101014000	Enhancers	ES-I3 Cell Line	embryonic stem cell
3	chr5:101013600-101014000	Enhancers	iPS-20b Cell Line	embryonic stem cell
4	chr5:101013600-101014400	Enhancers	HUES48 Cell Line	embryonic stem cell
5	chr5:101013600-101014400	Enhancers	iPS-18 Cell Line	embryonic stem cell
6	chr5:101013800-101014000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
7	chr5:101013800-101014000	Flanking Active TSS	A549	lung
8	chr5:101013800-101014000	Enhancers	NHDF-Ad	bronchial
9	chr5:101013800-101014200	Active TSS	Rectal Mucosa Donor 29	rectum
10	chr5:101013800-101014200	Bivalent Enhancer	HepG2	liver
11	chr5:101013800-101014400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr5:101013800-101014400	Enhancers	H9 Cell Line	embryonic stem cell
13	chr5:101013800-101014400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
14	chr5:101013800-101014400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
15	chr5:101013800-101014400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
16	chr5:101013800-101014400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr5:101013800-101014400	Enhancers	Aorta	Aorta
18	chr5:101013800-101014400	Enhancers	Esophagus	oesophagus
19	chr5:101013800-101014600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr5:101014000-101014200	Active TSS	HUES6 Cell Line	embryonic stem cell
21	chr5:101014000-101014200	Enhancers	Duodenum Mucosa	Duodenum
22	chr5:101014000-101014200	Active TSS	A549	lung
23	chr5:101014000-101014200	Weak transcription	Hela-S3	cervix
24	chr5:101014000-101014400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
25	chr5:101014000-101014400	Enhancers	H1 Cell Line	embryonic stem cell
26	chr5:101014000-101014400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
27	chr5:101014000-101014400	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr5:101014000-101014400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
29	chr5:101014000-101014400	Enhancers	Fetal Lung	lung
30	chr5:101014200-101014400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
31	chr5:101014200-101014400	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr5:101014200-101014400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
33	chr5:101014200-101014400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
34	chr5:101014200-101014400	Enhancers	Adipose Nuclei	Adipose
35	chr5:101014200-101014400	Enhancers	Brain Angular Gyrus	brain
36	chr5:101014200-101014400	Enhancers	Brain Anterior Caudate	brain
37	chr5:101014200-101014400	Flanking Bivalent TSS/Enh	Brain Inferior Temporal Lobe	brain
38	chr5:101014200-101014400	Enhancers	Brain Substantia Nigra	brain
39	chr5:101014200-101014400	Flanking Active TSS	Duodenum Mucosa	Duodenum
40	chr5:101014200-101014400	Enhancers	Fetal Stomach	stomach
41	chr5:101014200-101014400	Enhancers	Psoas Muscle	Psoas
42	chr5:101014200-101014400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
43	chr5:101014200-101014400	Enhancers	Rectal Mucosa Donor 31	rectum
44	chr5:101014200-101014400	Enhancers	Skeletal Muscle Male	skeletal muscle
45	chr5:101014200-101014400	Flanking Active TSS	A549	lung
46	chr5:101014200-101014400	Flanking Bivalent TSS/Enh	Dnd41	blood
47	chr5:101014200-101014400	Enhancers	Hela-S3	cervix
48	chr5:101014200-101014400	Enhancers	NH-A	brain
49	chr5:101014200-101014400	Enhancers	Osteobl	bone
50	chr5:101014200-101014600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links